Pay in 4 interest-free payments of $5.90 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
The honest version of the economic argument is: we have an evidence gap because the incentives are broken
Feng XH, Derynck R
Many owners resort to seeking cheaper alternatives or making compromises due to financial constraints, suggesting that these barriers may ultimately deter optimal pet care or even pet ownership altogether
A structure-based designed inhibitor of Bcr-Abl-T315I, ponatinib, was developed and used in the clinical trial
US$ 27.68
US$ 27.30
US$ 23.62
US$ 20.90
US$ 23.52
